ATX 14.9% 5.7¢ amplia therapeutics limited

Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-6

  1. 57 Posts.
    lightbulb Created with Sketch. 3
    Interesting results and hopefully the market sees the value at these levels, unless there is something they did not like or expected better ?

    I'm just looking at the Table they presented and all measures within the accent trial certainly show a better outcome,
    Considering phase 1B was not powered for efficacy surely makes the case more compelling.


 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
5.7¢
Change
-0.010(14.9%)
Mkt cap ! $15.48M
Open High Low Value Volume
6.5¢ 6.5¢ 5.6¢ $34.37K 568.7K

Buyers (Bids)

No. Vol. Price($)
1 50000 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 79035 2
View Market Depth
Last trade - 13.44pm 20/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.